Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4065262
Max Phase: Preclinical
Molecular Formula: C23H23BrN2O4
Molecular Weight: 391.45
Molecule Type: Small molecule
Associated Items:
ID: ALA4065262
Max Phase: Preclinical
Molecular Formula: C23H23BrN2O4
Molecular Weight: 391.45
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1cc(C(=O)C[n+]2ccc3c([nH]c4ccccc43)c2C)cc(OC)c1OC.[Br-]
Standard InChI: InChI=1S/C23H22N2O4.BrH/c1-14-22-17(16-7-5-6-8-18(16)24-22)9-10-25(14)13-19(26)15-11-20(27-2)23(29-4)21(12-15)28-3;/h5-12H,13H2,1-4H3;1H
Standard InChI Key: NKLMKVQUMRHRBF-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 391.45 | Molecular Weight (Monoisotopic): 391.1652 | AlogP: 3.83 | #Rotatable Bonds: 6 |
Polar Surface Area: 64.43 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 11.71 | CX Basic pKa: | CX LogP: -1.65 | CX LogD: -1.65 |
Aromatic Rings: 4 | Heavy Atoms: 29 | QED Weighted: 0.40 | Np Likeness Score: 0.23 |
1. Venkataramana Reddy PO, Mishra S, Tantak MP, Nikhil K, Sadana R, Shah K, Kumar D.. (2017) Design, synthesis and in vitro cytotoxicity studies of novel β-carbolinium bromides., 27 (6): [PMID:28254167] [10.1016/j.bmcl.2017.02.010] |
Source(1):